
10mg
❄️Lyophilized powder (not reconstituted)
Total: 33.35 GBP
Discount per Quantity
| Quantity | Discount | Price per Unit |
|---|---|---|
| 5 - 9 | 10% | 30.01 GBP |
| 10 - 19 | 20% | 26.68 GBP |
| 20+ | 30% | 23.34 GBP |
Rigorous third-party testing
Every batch of our research chemicals and peptides undergoes independent third-party laboratory testing for purity and identity.
Total: 33.35 GBP
Order within 13h 16m 52s · ships today
Cutoff 3:00 PM EET
Arrives Thu, Nov 12 – Mon, Nov 16
Free shipment protection
Lost or damaged parcels are replaced — refunded in full if a second one fails
Express 1–3 day delivery
Available at checkout
KPV is supplied as a catalogued research material in 10 mg.
The registry assignment above is for H-KPV-OH. KPV-NH2, an acetate or trifluoroacetate salt, and KPV embedded within alpha-MSH are distinct exact forms and must not inherit these identifiers without confirmation.
| Property | Value |
|---|---|
| Name and synonyms | Lys-Pro-Val, Lysyl-prolyl-valine |
| Material category | Anti-inflammatory peptide |
| Sequence | H-KPV-OH |
| Molecular formula | C16H30N4O4 |
| Average molecular mass | 342.44 g/mol |
| CAS Registry Number | 68461-36-9 |
| PubChem CID | CID 219045 |
| Structural features | Linear tripeptide, C-terminal fragment of alpha-Melanocyte-Stimulating Hormone (α-MSH). |
| Appearance | White to off-white lyophilised powder |
| Solubility | Readily soluble in water. |
| Physical form | Catalogue vial; exact salt/counter-ion and excipients are batch-specific and must be verified in the CoA and SDS. |
Registry values apply only to the specific molecular entity, sequence, termini and material form. Batch records take precedence over family-level literature identifiers.
A tripeptide with potent anti-inflammatory properties, acting independently of melanocortin receptors.
KPV has been examined in cell and mouse models addressing melanocortin-related signalling, epithelial responses and inflammatory assay endpoints. Experimental interpretation depends on chemical form, concentration, model and matrix.
The cited findings are preclinical, do not authenticate this batch and do not establish human-use outcomes. Results for full-length alpha-MSH or an amidated KPV form cannot be transferred to free-acid KPV without direct comparability.
| Aspect | This catalogue material | Comparator |
|---|---|---|
| Identity | H-Lys-Pro-Val-OH, free-acid tripeptide | Alpha-MSH: acetylated, amidated 13-residue peptide ending in KPV-NH2 |
| Structural distinction | Three-residue fragment lacking the central HFRW sequence of alpha-MSH | Full-length alpha-MSH has additional sequence, N-acetylation and C-terminal amidation |
| Analytical implication | Confirm sequence, intact mass, purity, free-acid terminus and counter-ion | Fragment origin does not establish identity with alpha-MSH or with KPV-NH2 |
Quality information is batch- and presentation-specific. Use only the report linked to the exact size and lot. A report listed for another size, lot or similarly named material must not be treated as evidence for this product.
Chromatographic area purity, identity, net peptide or analyte content, water or counter-ion content, sterility, endotoxin and elemental impurities are different measurements. One result does not establish the others. Only tests supported by a visible, matching report should be regarded as available.
Store and handle only under the conditions stated on the product label, batch CoA and SDS. Keep the container secured, correctly identified and protected from contamination. Do not infer storage, solvent compatibility or stability from a related compound.
Laboratory preparation, analytical-method selection, risk assessment, personal protective equipment and waste disposal should follow the applicable SDS and the institution's approved procedures.
| Research-use notice | This material is supplied exclusively for laboratory research by qualified professionals and is not intended for human or veterinary use. Purchasers are responsible for compliance with applicable local requirements. |
Only when the exact sequence or structure, termini, conjugation, salt or counter-ion and hydration state match. The batch CoA and SDS govern; a related-compound identifier must not be substituted.
It is method- and report-specific. For example, an HPLC area percentage is not automatically the same as identity, net content, sterility, endotoxin status or absence of elemental impurities.
Follow the exact label, batch CoA and SDS together with the institution's risk assessment. Use only storage and stability information linked to the exact material form and batch.
This site does not provide medical advice. These statements have not been evaluated by the FDA or the European Medicines Agency (EMA). Products are not drugs and are not intended to diagnose, treat, cure, or prevent any disease.
Enter your email to receive promo codes, special offers and the latest updates.
Occasional emails only. Unsubscribe anytime.